| Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan V Haksoyler, A A Besen, T Koseci, P Olgun, E Bayram, E Topkan Biomarkers in Medicine 15 (11), 851-859, 2021 | 12 | 2021 |
| Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes E Esin, B Oksuzoglu, A Bilici, I Cicin, O Kostek, MA Kaplan, S Aksoy, ... Cancer chemotherapy and pharmacology 83, 131-143, 2019 | 7 | 2019 |
| Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint … P Olgun, O Diker Current Oncology 30 (12), 10539-10549, 2023 | 4 | 2023 |
| Development of a novel predictive-prognostic scoring index for immune checkpoint inhibitors in advanced non-small cell lung cancer O Diker, P Olgun, U Balyemez, SS Ikiz Cureus 15 (1), 2023 | 4 | 2023 |
| Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma. T Koseci, V Haksoyler, P Olgun, S Ata, E Nayir, BB Duman, T Cil Clinical Laboratory 68 (2), 2022 | 3 | 2022 |
| Association of the immune-inflammation-nutritional parameters with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer Ö DİKER, P OLGUN J Oncological Sci 8 (1), 43-53, 2022 | 3 | 2022 |
| First-line pembrolizumab efficacy in patients with advanced non-small cell lung cancer: a bi-center retrospective, real-life experience study O Diker, P Olgun J BUON 26 (3), 844-852, 2021 | 3 | 2021 |
| Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors P Olgun, O Diker Current Medical Research and Opinion 39 (3), 425-431, 2023 | 2 | 2023 |
| Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience O Diker, BY Aktas, R Ak, B Koylu, O Bas, H Taban, DC Guven, P Olgun, ... Future Oncology 18 (3), 323-331, 2021 | 2 | 2021 |
| Efficacy of palbociclib and endocrine treatment in heavily pretreated hormone receptor-positive/HER2-negative advanced breast cancer: retrospective multicenter trial A Demir, NM Mandel, S Paydas, G Demir, Ö Er, NS Turhal, S Bavbek, ... Balkan medical journal 37 (2), 104, 2020 | 2 | 2020 |
| A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey I Boga, SO Sag, N Duman, SY Ozdemir, MC Ergoren, K Dalci, C Mujde, ... European journal of breast health 19 (3), 235, 2023 | 1 | 2023 |
| Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: a retrospective evaluation of 149 cases T Koseci, P Olgun, S Ata, M Seyyar, ZA Tas, E Bayram, BB Duman, T Cil Eurasian J Med Invest 6, 222-6, 2022 | 1 | 2022 |
| Male breast cancer: clinical, demographical, and pathological features in a cohort of 41 patients T Koseci, V Haksöyler, P Olgun, MB Koyuncu, BB Duman, T Çil Cureus 13 (9), 2021 | 1 | 2021 |
| Pre-treatment pan-immune-inflammation value (PIV) and pile prognostic score in patients treated with immunotherapy. P Olgun, O Diker Medicine Science 12 (4), 2023 | | 2023 |
| Diagnostic Significance of Pre-Treatment Prognostic Nutritional Index, Platelet/Albumin Ratio and Red Cell Distribution Width in Patients with Differentiated Glioblastoma from … P Olgun, T Koseci, E Bayram, V Haksoyler, BB Duman, T Cil Eurasian Journal of Medical Investigation 7 (4), 2023 | | 2023 |
| Enzalutamide in Metastatic Castration-Resistant Prostate Cancer, Real-World Data. A Bahceci, AM Sedef, G Aktas, P Olgun, HY Cinkir, H Taskaynatan, T Kus Eurasian Journal of Medical Investigation 7 (1), 2023 | | 2023 |
| Salvage chemotherapy in patients with nonsmall cell lung cancer after prior immunotherapy: a retrospective, real-life experience study O Diker, P Olgun Anti-Cancer Drugs 33 (8), 752-757, 2022 | | 2022 |
| Erişkin Dönemin Nadir Görülen Beyin Tümörü: Medulloblastom Tanılı 28 Hastanın Demografik Özellikleri T Köşeci, S Ata, M Seyyar, P Olgun, E Bayram, K Eser, ZA Taş Journal of Cukurova Anesthesia and Surgical Sciences 5 (2), 235-240, 2022 | | 2022 |
| A multicenter study of genotype variation/demographic patterns in 2475 individuals inluding with 1444 cases with breast cancer in Turkey Short Title: BRCA profiling of breast … A Bisgin, SO Sag, N Duman, SY Ozdemir, MC Ergoren, I Boga, K Dalci, ... | | 2022 |
| Real-World Data of Nivolumab and Pembrolizumab in Platinum Refractory Advanced Non-Small Cell Lung Cancer: Potential Practical Predictors of Treatment. O Diker, P Olgun UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2022 | | 2022 |
